Published
on
April 28, 2017
|
members are following updates on this item.
OfflinePatient engagement a new frontier for drug makers
Right now, any interaction between drug companies and patients typically comes after a drug has been developed and released, when drug makers look to patients to provide “patient reported outcomes” to determine whether a drug is having its intended effects and meeting patients’ expectations.
However, the push is to engage patients earlier in the process...
Page Options